Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00302640

Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Multi-center, Double-blind, Placebo-controlled Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children

Sponsor: Romark Laboratories L.C.

Conditions Adenoviridae Infection Norovirus Infection Rotavirus Infection

Interventions Alinia (nitazoxanide)

Updated 6 times since 2017 Last updated: May 30, 2012 Started: Feb 28, 2005 Completion: Sep 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Adenoviridae Infection and Norovirus Infection and is currently completed. Romark Laboratories L.C. leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Romark Laboratories L.C.

Data source: Romark Laboratories L.C.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.